BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang L, Zhang S, Wang X. The Metabolic Mechanisms of Breast Cancer Metastasis. Front Oncol 2020;10:602416. [PMID: 33489906 DOI: 10.3389/fonc.2020.602416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Cheng W, Xiao X, Liao Y, Cao Q, Wang C, Li X, Jia Y. Conducive target range of breast cancer: Hypoxic tumor microenvironment. Front Oncol 2022;12:978276. [DOI: 10.3389/fonc.2022.978276] [Reference Citation Analysis]
2 Orzechowska-licari EJ, Lacomb JF, Mojumdar A, Bialkowska AB. SP and KLF Transcription Factors in Cancer Metabolism. IJMS 2022;23:9956. [DOI: 10.3390/ijms23179956] [Reference Citation Analysis]
3 Baldasici O, Pileczki V, Cruceriu D, Gavrilas LI, Tudoran O, Balacescu L, Vlase L, Balacescu O. Breast Cancer-Delivered Exosomal miRNA as Liquid Biopsy Biomarkers for Metastasis Prediction: A Focus on Translational Research with Clinical Applicability. Int J Mol Sci 2022;23:9371. [PMID: 36012638 DOI: 10.3390/ijms23169371] [Reference Citation Analysis]
4 Shrivastava N, Parikh A, Dewangan RP, Biswas L, Verma AK, Mittal S, Ali J, Garg S, Baboota S. Solid Self-Nano Emulsifying Nanoplatform Loaded with Tamoxifen and Resveratrol for Treatment of Breast Cancer. Pharmaceutics 2022;14:1486. [DOI: 10.3390/pharmaceutics14071486] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Stringer E, Lum JJ, Macpherson N. Intermittent Fasting in Cancer: a Role in Survivorship? Curr Nutr Rep. [DOI: 10.1007/s13668-022-00425-0] [Reference Citation Analysis]
6 Saponaro C, Fanizzi A, Sonnessa M, Mondelli P, Vergara D, Loisi D, Massafra R, Latorre A, Zito FA, Schirosi L. Downstream Signaling of Inflammasome Pathway Affects Patients’ Outcome in the Context of Distinct Molecular Breast Cancer Subtypes. Pharmaceuticals 2022;15:651. [DOI: 10.3390/ph15060651] [Reference Citation Analysis]
7 Zou R, Zhao W, Xiao S, Lu Y. A Signature of Three Apoptosis-Related Genes Predicts Overall Survival in Breast Cancer. Front Surg 2022;9:863035. [DOI: 10.3389/fsurg.2022.863035] [Reference Citation Analysis]
8 Chen Y, Wang Y, Hou K, Lin M, Lin Y, Chuang H, Lee Y. Use of piggyBac Transposon System Constructed Murine Breast Cancer Model for Reporter Gene Imaging and Characterization of Metastatic Tumor Cells. J Med Biol Eng . [DOI: 10.1007/s40846-022-00703-w] [Reference Citation Analysis]
9 Capeloa T, Krzystyniak J, Rodriguez AC, Payen VL, Zampieri LX, Pranzini E, Derouane F, Vazeille T, Bouzin C, Duhoux FP, Murphy MP, Porporato PE, Sonveaux P. MitoQ Prevents Human Breast Cancer Recurrence and Lung Metastasis in Mice. Cancers (Basel) 2022;14:1488. [PMID: 35326639 DOI: 10.3390/cancers14061488] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Wang Y, Chen X, Tian Y, Liu L, Su P. Decreased Expression of circ_0000160 in Breast Cancer With Axillary Lymph Node Metastasis. Front Mol Biosci 2022;8:690826. [DOI: 10.3389/fmolb.2021.690826] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Suteau V, Bukasa-Kakamba J, Virjogh-Cenciu B, Adenis A, Sabbah N, Drak Alsibai K. Pathological Significance of GLUT-1 Expression in Breast Cancer Cells in Diabetic and Obese Patients: The French Guiana Study. Cancers (Basel) 2022;14:437. [PMID: 35053598 DOI: 10.3390/cancers14020437] [Reference Citation Analysis]
12 Ban B, Zhang K, Li JN, Liu TJ, Shi J. Ductal breast carcinoma metastasized to the rectum: A case report and review of the literature. World J Clin Cases 2021; 9(36): 11346-11354 [DOI: 10.12998/wjcc.v9.i36.11346] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Santos RA, Andrade EDS, Monteiro M, Fialho E, Silva JL, Daleprane JB, Ferraz da Costa DC. Green Tea (Camellia sinensis) Extract Induces p53-Mediated Cytotoxicity and Inhibits Migration of Breast Cancer Cells. Foods 2021;10:3154. [PMID: 34945706 DOI: 10.3390/foods10123154] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Al-Taie Z, Hannink M, Mitchem J, Papageorgiou C, Shyu CR. Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer. Cancers (Basel) 2021;13:6278. [PMID: 34944904 DOI: 10.3390/cancers13246278] [Reference Citation Analysis]
15 Li L, Jiang K, Li D, Li D, Fan Z, Dai G, Tu S, Liu X, Wei G. The Chemokine CXCL7 Is Related to Angiogenesis and Associated With Poor Prognosis in Colorectal Cancer Patients. Front Oncol 2021;11:754221. [PMID: 34692540 DOI: 10.3389/fonc.2021.754221] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Saatci O, Huynh-Dam KT, Sahin O. Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies. J Mol Med (Berl) 2021;99:1691-710. [PMID: 34623477 DOI: 10.1007/s00109-021-02136-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ghosh M, Das S. PRAMEF2-mediated dynamic regulation of YAP signaling promotes tumorigenesis. Proc Natl Acad Sci U S A 2021;118:e2105523118. [PMID: 34593639 DOI: 10.1073/pnas.2105523118] [Reference Citation Analysis]
18 Gómez-Cebrián N, Domingo-Ortí I, Poveda JL, Vicent MJ, Puchades-Carrasco L, Pineda-Lucena A. Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments. Cancers (Basel) 2021;13:4544. [PMID: 34572770 DOI: 10.3390/cancers13184544] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Bryan S, Witzel I, Borgmann K, Oliveira-Ferrer L. Molecular Mechanisms Associated with Brain Metastases in HER2-Positive and Triple Negative Breast Cancers. Cancers (Basel) 2021;13:4137. [PMID: 34439289 DOI: 10.3390/cancers13164137] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
20 Liu T, Wang J, Sun L, Li M, He X, Jiang J, Zhou Q. Piwi-interacting RNA-651 promotes cell proliferation and migration and inhibits apoptosis in breast cancer by facilitating DNMT1-mediated PTEN promoter methylation. Cell Cycle 2021;20:1603-16. [PMID: 34313525 DOI: 10.1080/15384101.2021.1956090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]